Investment Opportunities

IPO Calendar: Upcoming Investing Opportunities | Investment U

Companies release their IPO details at unpredictable times. That’s why we update this IPO calendar daily to give you the most up-to-date information available. To start, let’s look at this week’s IPOs.

This Week’s IPOs

Date Company Ticker Symbol Price Shares
August 3, 2021 Healthwell Acquisition I Nasdaq: HWELU $10 25,000,000
August 4, 2021 AMCI Acquisition II Nasdaq: AMCIU $10 15,000,000
August 4, 2021 Blue Whale Acquisition I Nasdaq: BWCAU $10 20,000,000
August 4, 2021 IDW Media Holdings NYSE: IDW $3.60 2,500,000
August 5, 2021 Cadre Holdings NYSE: CDRE $16-19 7,142,857
August 5, 2021 European Wax Center Nasdaq: EWCZ $17 10,600,000
August 5, 2021 Orange County Bancorp Nasdaq: OBT $33.50 900,000
August 5, 2021 Gladstone Acquisition Nasdaq: GLEEU $10 10,000,000
August 5, 2021 Weber NYSE: WEBR $14 17,857,143
August 6, 2021 Adagio Therapeutics Nasdaq: ADGI $16-18 17,700,000
August 6, 2021 Eliem Therapeutics Nasdaq: ELYM $17-19 4,500,000
August 6, 2021 Healthcare Royalty NYSE: HCRX $15-17 46,875,000

Upcoming IPOs

If you’re interested in IPO investing, check out our Top Recent IPOs. And if you’re looking for the latest investment opportunities, you’re in the right place! Sign up for our free Investment U e-letter to receive daily tips and research from our experts. Whether you’re a beginner or an experienced investor, there’s something for everyone.

IPO Calendar Highlights

WCG Clinical (Nasdaq: WCGC)

Highlights from WCG Clinical’s prospectus include…


We believe we are a leading provider of clinical trial solutions, focused on providing solutions that are designed to measurably improve the quality and efficiency of clinical research, stimulate growth and foster compliance. Our transformational solutions enable biopharmaceutical companies, contract research organizations, and institutions to accelerate the delivery of new treatments and therapies to patients, while maintaining the highest standards of human protection.

Our solutions include software as well as technology-enabled clinical services that provide integrated, end-to-end support along the clinical trial process. Our clients leverage our solutions to inform the critical decisions that are key to saving significant time and expense, enhancing drug safety and efficacy, and ultimately allowing for the improvement of millions of lives.


WCG’s mission is to provide clinical trial stakeholders with the highest-quality service, accelerate the scientific advancement of human health, and ensure that the risks of progress never outweigh the value of human life.

Weber (NYSE: WEBR)

Highlights from Weber’s prospectus include…


We are the leading outdoor cooking company with the strongest and most trusted brand in the global outdoor cooking market … we have built a loyal and global following of both grilling enthusiasts and barbeque professionals in backyards all around the world. We have continuously disrupted and led the outdoor cooking category, through a comprehensive and expanding product portfolio including traditional charcoal grills, gas grills, smokers, pellet and electric grills, and recently our cutting-edge Weber Connect™ technology-enabled grills. We believe we offer the most complete outdoor cooking portfolio globally, with our full range of premium products sold in 78 countries in fiscal 2020.


We believe Weber is the only outdoor cooking brand with global scale and a vertically integrated manufacturing platform. Our track record of premium product innovation and the strength of our brand has led to a market-leading share of 23% in the U.S. and 24% globally in 2020, according to Frost & Sullivan. We are leaders in the largest and most attractive markets in outdoor cooking, including the U.S., Germany, Australia, Canada and France. Beyond these markets, we estimate that we have either the number one or number two brand position in each of the key geographies we serve.

Mission and Purpose

Our mission at Weber is to lead the outdoor cooking industry by innovating breakthrough new products and services that enhance our global consumers’ grilling experiences. Our purpose is to ignite inspiration and discovery through everything we do, at every touchpoint with our consumers. Grilling is about making delicious food, bringing people together and creating memories. Weber is an experience, a passion, a way of life and a journey to discover what grilling can be.

Healthcare Royalty (NYSE: HCRX)

Highlights from Healthcare Royalty’s prospectus include…


We are the leading mid-market royalty acquisition company, based upon the number of transactions and aggregate value of capital deployed since 2016. We focus on growth assets and emerging companies driving innovation in the biopharmaceutical industry. We consider “mid-market” to comprise royalty acquisitions for transaction sizes between $20 million and $250 million.


Our mission is to facilitate innovation by deploying capital consistently and reliably in products that serve unmet or underserved medical needs. We intend to achieve this mission by expanding our portfolio of approved and pre-approval products using cash flow generated by our existing portfolio as well as capital raised in the public equity market and debt raised in the public and private markets.

Market Opportunity

Royalties play a fundamental and growing role in the biopharmaceutical industry. The increasing complexity and cost of drug development today typically involves a number of industry participants, resulting in an increased pipeline of royalties … The persistent funding needs of royalty holders, primarily emerging biopharmaceutical companies, has led to a robust royalty acquisition and related debt financing market that we estimate reached a record $9.5 billion in 2020.

The IPO calendar this week presents some unique investing opportunities. If you’re looking for more insight, Investment U is the place to be. Sign up for our free e-letter below! It’s full of useful tips and research from our experts. Whether you’re a beginner or an experienced investor, Investment U has something for everyone.


Aimee Bohn graduated from the College of Business and Economics at Towson University. Her background in marketing research helps her uncover valuable trends. Researching IPOs and other trends has been her primary focus over the past year. When Aimee isn’t writing for Investment U, you can usually find her doing graphic design or traveling with friends.

Articles by

Related Articles

Investor Survey

IU Masterplan
Popular Posts